• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病视网膜病变概述

Diabetic retinopathy, an overview.

作者信息

Hartnett M Elizabeth, Baehr Wolfgang, Le Yun Z

机构信息

Department of Ophthalmology, John A. Moran Eye Center, University of Utah Health Sciences, Salt Lake City, UT 84132, United States.

Department of Ophthalmology, John A. Moran Eye Center, University of Utah Health Sciences, Salt Lake City, UT 84132, United States.

出版信息

Vision Res. 2017 Oct;139:1-6. doi: 10.1016/j.visres.2017.07.006. Epub 2017 Aug 4.

DOI:10.1016/j.visres.2017.07.006
PMID:28757399
Abstract

This overview introduces contributions to a special issue on causes of vision loss from diabetes mellitus, focusing on the retina and also the cornea. Diabetic retinopathy is the most common and leading cause of vision loss among people with diabetes. Research to detect early symptoms, understand mechanisms leading to diabetic eye disease, and the development of treatments is a highly active research area, with currently about 2000 scientific publication per year. We provide a series of 27 comprehensive reviews and research articles from leading experts in the field.

摘要

本综述介绍了关于糖尿病致视力丧失原因的特刊文章,重点关注视网膜和角膜。糖尿病视网膜病变是糖尿病患者中最常见且主要的视力丧失原因。检测早期症状、了解导致糖尿病眼病的机制以及开发治疗方法的研究是一个非常活跃的研究领域,目前每年约有2000篇科学出版物。我们提供了该领域顶尖专家撰写的27篇全面的综述和研究文章。

相似文献

1
Diabetic retinopathy, an overview.糖尿病视网膜病变概述
Vision Res. 2017 Oct;139:1-6. doi: 10.1016/j.visres.2017.07.006. Epub 2017 Aug 4.
2
Visual dysfunction associated with diabetic retinopathy.与糖尿病视网膜病变相关的视觉功能障碍。
Curr Diab Rep. 2010 Oct;10(5):380-4. doi: 10.1007/s11892-010-0132-4.
3
New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets.糖尿病视网膜病变病理生理学的新见解:潜在的细胞特异性治疗靶点。
Diabetes Technol Ther. 2000 Winter;2(4):601-8. doi: 10.1089/15209150050502023.
4
A new view of diabetic retinopathy: a neurodegenerative disease of the eye.糖尿病视网膜病变的新观点:一种眼部神经退行性疾病。
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):283-90. doi: 10.1016/S0278-5846(03)00023-X.
5
Recent advances in the management of diabetic retinopathy.糖尿病视网膜病变管理的最新进展。
Drug Discov Today. 2019 Aug;24(8):1499-1509. doi: 10.1016/j.drudis.2019.03.028. Epub 2019 Apr 4.
6
Multifocal Pupillography Identifies Changes in Visual Sensitivity According to Severity of Diabetic Retinopathy in Type 2 Diabetes.多焦点瞳孔造影术可根据2型糖尿病患者糖尿病视网膜病变的严重程度确定视觉敏感度的变化。
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4504-13. doi: 10.1167/iovs.15-16712.
7
The prevalence and severity of diabetic retinopathy, associated risk factors and vision loss in patients registered with type 2 diabetes in Luganville, Vanuatu.瓦努阿图卢甘维尔2型糖尿病登记患者中糖尿病视网膜病变的患病率、严重程度、相关危险因素及视力丧失情况
Br J Ophthalmol. 2007 Apr;91(4):415-9. doi: 10.1136/bjo.2006.104174. Epub 2006 Oct 31.
8
Diabetes and Healthy Eyes Toolkit: a community health worker program to prevent vision loss and blindness among people with diabetes.糖尿病与健康眼睛工具包:一个面向社区卫生工作者的项目,旨在预防糖尿病患者视力丧失和失明。
Fam Community Health. 2012 Apr-Jun;35(2):103-10. doi: 10.1097/FCH.0b013e3182464fc0.
9
Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.口服蛋白激酶 Cβ 抑制剂罗格列酮治疗糖尿病视网膜病变:蛋白激酶 Cβ 抑制剂-糖尿病视网膜病变研究和蛋白激酶 Cβ 抑制剂-糖尿病视网膜病变研究 2 中 813 例(1392 只眼)糖尿病视网膜病变患者的疗效、安全性和视力丧失的原因。
Retina. 2011 Nov;31(10):2084-94. doi: 10.1097/IAE.0b013e3182111669.
10
Trends in the incidence of visual impairment certification secondary to diabetic retinopathy in the Leeds metropolitan area, 2005-2010.2005-2010 年利兹都会区糖尿病视网膜病变导致视力损害认证发病率的趋势。
Diabet Med. 2012 Jul;29(7):e112-6. doi: 10.1111/j.1464-5491.2012.03619.x.

引用本文的文献

1
The Effect of Glucagon-like-Peptide-1 Receptor Agonists on Diabetic Retinopathy Progression, Central Subfield Thickness, and Response to Intravitreal Injections.胰高血糖素样肽-1受体激动剂对糖尿病视网膜病变进展、中心子野厚度及玻璃体内注射反应的影响。
J Clin Med. 2024 Oct 21;13(20):6269. doi: 10.3390/jcm13206269.
2
Retinal Cell Damage in Diabetic Retinopathy.糖尿病性视网膜病变中的视网膜细胞损伤。
Cells. 2023 May 8;12(9):1342. doi: 10.3390/cells12091342.
3
Prevalence and risk factors of diabetic retinopathy in Basrah, Iraq.伊拉克巴士拉的糖尿病视网膜病变患病率及其危险因素。
J Med Life. 2023 Feb;16(2):299-306. doi: 10.25122/jml-2022-0170.
4
Combining transfer learning with retinal lesion features for accurate detection of diabetic retinopathy.将迁移学习与视网膜病变特征相结合以实现糖尿病视网膜病变的准确检测。
Front Med (Lausanne). 2022 Nov 8;9:1050436. doi: 10.3389/fmed.2022.1050436. eCollection 2022.
5
Complement 3a Mediates CCN2/CTGF in Human Retinal Pigment Epithelial Cells.补体3a在人视网膜色素上皮细胞中介导CCN2/结缔组织生长因子。
J Ophthalmol. 2022 Jul 30;2022:3259453. doi: 10.1155/2022/3259453. eCollection 2022.
6
Prevalence and Factors Associated with Diabetic Retinopathy among Adult Diabetes Patients in Southeast Ethiopia: A Hospital-Based Cross-Sectional Study.埃塞俄比亚东南部成年糖尿病患者糖尿病视网膜病变的患病率及相关因素:一项基于医院的横断面研究
Clin Ophthalmol. 2022 Oct 20;16:3527-3545. doi: 10.2147/OPTH.S385806. eCollection 2022.
7
The Emerging Role of Pericyte-Derived Extracellular Vesicles in Vascular and Neurological Health.周细胞衍生细胞外囊泡在血管和神经健康中的新作用。
Cells. 2022 Oct 2;11(19):3108. doi: 10.3390/cells11193108.
8
Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective.糖尿病视网膜病变和糖尿病性黄斑水肿的新型治疗方法:病理生理学视角
Front Physiol. 2022 Feb 18;13:831616. doi: 10.3389/fphys.2022.831616. eCollection 2022.
9
Intravitreal Injection for Diabetic Macular Edema as Adjunctive Therapy for Proliferative Diabetic Retinopathy: A Retrospective Study.玻璃体内注射治疗糖尿病性黄斑水肿作为增殖性糖尿病视网膜病变的辅助治疗:一项回顾性研究
Clin Ophthalmol. 2022 Jan 14;16:135-143. doi: 10.2147/OPTH.S346065. eCollection 2022.
10
Increasing Angiogenesis Factors in Hypoxic Diabetic Wound Conditions by siRNA Delivery: Additive Effect of LbL-Gold Nanocarriers and Desloratadine-Induced Lysosomal Escape.通过 siRNA 递送来增加缺氧糖尿病创面条件下的血管生成因子:LbL 金纳米载体和地氯雷他定诱导的溶酶体逃逸的附加效应。
Int J Mol Sci. 2021 Aug 26;22(17):9216. doi: 10.3390/ijms22179216.